The temporal and spatial variability of scavening ratios for nss sulfate, nitrate, methanesulfonate and sodium in the atmosphere over the north atlantic ocean / by Galloway, J. W.

Baseline retinal testing is no longer recommended for hydroxychloroquine users in the United Kingdom by Yusuf, I, Bukhari, M, Galloway, J, Lotery, AJ

Monitoring for retinal toxicity in patients taking hydroxychloroquine and chloroquine by Yusuf, IH, Ledingham, JM, MacPhie, E, Lotery, AJ, Galloway, J

Effects of moisture changes on flexural and fatigue strength of concrete / by 346207 Galloway, J. W., Harding, H. M., Raithby, K. D., Great Britain. Road Research Laboratory

Cardiovascular risk factors and outcomes in early rheumatoid arthritis: a population-based study by Nikiphorou, E, de Lusignan, S, Mallen, C, Khavandi, K, Bedarida, G, Buckley, C, Galloway, J, Raza, K

Risk of venous thromboembolism in immune-mediated inflammatory diseases: a UK matched cohort study by Galloway, J, Barrett, K, Irving, P, Khavandi, K, Nijher, M, Nicholson, R, de Lusignan, S, Buch, MH

Haematological abnormalities in new onset rheumatoid arthritis and risk of common infections: a population-based study by Nikiphorou, E, De Lusignan, S, Mallen, C, Khavandi, K, Roberts, J, Buckley, C, Galloway, J, Raza, K

Prognostic value of comorbidity indices and lung diseases in early rheumatoid arthritis: a UK population-based study. by Nikiphorou, E, De Lusignan, S, Mallen, C, Roberts, J, Khavandi, K, Bedarida, G, Buckley, C, Galloway, J, Raza, K

The Royal College of Ophthalmologists recommendations on screening for hydroxychloroquine and chloroquine users in the United Kingdom: executive summary by Yusuf, IH, Foot, B, Galloway, J, Ardern-Jones, MR, Watson, S-L, Yelf, C, Burdon, MA, Bishop, PN, Lotery, AJ

Baricitinib safety for events of special interest in populations at risk: analysis from randomised trial data across rheumatologic and dermatologic indications by Taylor, PC, Bieber, T, Alten, R, Witte, T, Galloway, J, Deberdt, W, Issa, M, Haladyj, E, De La Torre, I, Grond, S, Wollenberg, A

Diagnostic delay and less intensive therapy for people with psoriatic arthritis compared with rheumatoid arthritis: a study nested within an English and Welsh audit dataset by Charlton, RA, Gates, E, Coates, LC, Galloway, J, McHugh, N, McGrogan, A, Hackett, S, Brooke, M, Cavill, C, Tillett, W

Enhancing current guidance for psoriatic arthritis and its comorbidities: recommendations from an expert consensus panel by Coates, LC, Bukhari, M, Chan, A, Choy, E, Galloway, J, Gullick, N, Kent, A, Savage, L, Siebert, S, Tillett, W, Wood, N, Conaghan, PG

An investigation of levetiracetam in Alzheimer's disease (ILiAD): a double-blind, placebo-controlled, randomised crossover proof of concept study by Sen, A, Akinola, M, Tai, XY, Symmonds, M, Davis Jones, G, Mura, S, Galloway, J, Hallam, A, Chan, JYC, Koychev, I, Butler, C, Geddes, J, Van Der Putt, R, Thompson, S, Manohar, SG, Frangou, E, Love, S, McShane, R, Husain, M

Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomise... by Rivellese, F, Nerviani, A, Giorli, G, Warren, L, Jaworska, E, Bombardieri, M, Lewis, MJ, Humby, F, Pratt, AG, Filer, A, Gendi, N, Cauli, A, Choy, E, McInnes, I, Durez, P, Edwards, CJ, Buch, MH, Gremese, E, Taylor, PC, Ng, N, Cañete, JD, Raizada, S, McKay, ND, Jadon, D, Sainaghi, PP, Stratton, R, Ehrenstein, M, Ho, P, Pereira, JP, Dasgupta, B, Gorman, C, Galloway, J, Chinoy, H, van der Heijde, D, Sasieni, P, Barton, A, Pitzalis, C

Safety and efficacy of NVX-CoV2373 Covid-19 vaccine by Heath, PT, Galiza, EP, Baxter, DN, Boffito, M, Browne, D, Burns, F, Chadwick, DR, Clark, R, Cosgrove, C, Galloway, J, Goodman, AL, Heer, A, Higham, A, Iyengar, S, Jamal, A, Jeanes, C, Kalra, PA, Kyriakidou, C, McAuley, DF, Meyrick, A, Minassian, AM, Minton, J, Moore, P, Munsoor, I, Nicholls, H, Osanlou, O, Packham, J, Pretswell, CH, San Francisco Ramos, A, Saralaya, D, Sheridan, RP, Smith, R, Soiza, RL, Swift, PA, Thomson, EC, Turner, J, Viljoen, ME, Albert, G, Cho, I, Dubovsky, F, Glenn, G, Rivers, J, Robertson, A, Smith, K, Toback, S

Safety and efficacy of the NVX-CoV2373 coronavirus disease 2019 vaccine at completion of the placebo-controlled phase of a randomized controlled trial by Heath, PT, Galiza, EP, Baxter, DN, Boffito, M, Browne, D, Burns, F, Chadwick, DR, Clark, R, Cosgrove, CA, Galloway, J, Goodman, AL, Heer, A, Higham, A, Iyengar, S, Jeanes, C, Kalra, PA, Kyriakidou, C, Bradley, JM, Munthali, C, Minassian, AM, McGill, F, Moore, P, Munsoor, I, Nicholls, H, Osanlou, O, Packham, J, Pretswell, CH, San Francisco Ramos, A, Saralaya, D, Sheridan, RP, Smith, R, Soiza, RL, Swift, PA, Thomson, EC, Turner, J, Viljoen, ME, Fries, L, Cho, I, McKnight, I, Glenn, G, Rivers, EJ, Robertson, A, Alves, K, Smith, K, Toback, S